Sitemap

About Us (RedirectPage)
Newsroom (newsroom)
- DRAFT ONLY (contentTopForLists)
- 2013 (contentTopForLists)
  - Now Open Broad Agency Announcements (NewsroomArticles)
  - FFMN Solicitation No 13-100-SOL-0000 (NewsroomExternalLinks)
  - HHSAwardADDevelopmentNovelFlu (NewsroomExternalLinks)
  - PAHPA (NewsroomExternalLinks)
  - Smart DME-Power Generation RFI (NewsroomExternalLinks)
  - RFIAgentsTreatmentNewThreats (NewsroomExternalLinks)
  - FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
  - Lurie_FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
  - Clinical_Studies_Network_RFP (NewsroomExternalLinks)
  - TestIdentifyResistantFlu (NewsroomExternalLinks)
  - PresolicitationAncillaryInfluPreparedness (NewsroomExternalLinks)
  - StrategicAllianceDevAntibiotics (NewsroomExternalLinks)
  - BARDA Proposal Public Health and Medical Consequence Modeling Network (NewsroomExternalLinks)
  - BARDA Supports New Broad-Spectrum Antibiotic Drug (NewsroomExternalLinks)
  - Pre-Solicitation Notice for the Advanced Research and Development (NewsroomExternalLinks)
  - Pre-Solicitation Notice for Science and Technology Platforms (NewsroomExternalLinks)
  - Pre-Solicitation Notice for the Advancement of Medical Countermeasures (NewsroomExternalLinks)
  - HHSBAANewsRelease (NewsroomExternalLinks)
  - BAAPreProposalConference (NewsroomExternalLinks)
  - SmallMoleculeDev (NewsroomExternalLinks)
  - PBS_Report_2012 (NewsroomExternalLinks)
  - EvalSevereThermalBurns (NewsroomExternalLinks)
  - BARDA evaluates burn dressing for radiation, sulfur mustard burns (NewsroomExternalLinks)
  - BARDA funds study of therapy for thermal burns (NewsroomExternalLinks)
  - HHS replenishes nation’s supply of anthrax antitoxin (NewsroomExternalLinks)
  - HHS pursues nerve agent anti-seizure drug for children and adults (NewsroomArticles)
  - HHS boosts stockpile of products to treat acute radiation syndrome (NewsroomExternalLinks)
  - HHS boosts national capacity to produce pandemic flu vaccine (NewsroomExternalLinks)
  - HHSNewBloodAnthraxTest (NewsroomExternalLinks)
- 2014 (contentTopForLists)
  - Drug_Bioterrorism_Antimicrobial-resistant_Infections (NewsroomExternalLinks)
  - network to perform clinical studies (NewsroomExternalLinks)
  - Now Open Broad Agency Announcements (NewsroomArticles)
  - BID2014_RegistrationOpen (NewsroomExternalLinks)
  - CIADM_RTOR_Pfenex (NewsroomExternalLinks)
  - Establish Adjuvant Hub (NewsroomExternalLinks)
  - CIADM_RTOR_Vaxin (NewsroomExternalLinks)
  - EbolaFAQ (NewsroomExternalLinks)
  - MappEbolaDevelopment (NewsroomExternalLinks)
  - ProfectusEbolaVaccine (NewsroomExternalLinks)
  - BARDA Chem and RadNuc Animal Model Development (NewsroomExternalLinks)
  - develop next-generation portable ventilator (NewsroomExternalLinks)
  - severe infections and prevent cytokine storm (NewsroomExternalLinks)
  - detection tests for influenza (NewsroomExternalLinks)
  - speed Ebola vaccine delivery (NewsroomExternalLinks)
- 2022 (contentTopForLists)
  - biomac (NewsroomArticles)
  - PBS (NewsroomArticles)
  - Detect Inc (NewsroomArticles)
  - lilly_mab (NewsroomExternalLinks)
  - PanFluPreparedness (NewsroomArticles)
  - Lumen (NewsroomArticles)
  - SAMMIES (NewsroomArticles)
  - NextGenDiagnostic (NewsroomArticles)
  - CARB-X (NewsroomExternalLinks)
  - BARDAStrategy (NewsroomExternalLinks)
  - BID2022Save (NewsroomArticles)
  - Crossject (NewsroomArticles)
  - monkeypox_order (NewsroomExternalLinks)
  - Bebtelovimab_purchase (NewsroomExternalLinks)
  - 105mdoses (NewsroomExternalLinks)
  - AddressingAMR (NewsroomExternalLinks)
- 2015 (contentTopForLists)
  - 2014 PHEMCE SIP (NewsroomExternalLinks)
  - CRO Nonclinical Studies SB (NewsroomExternalLinks)
  - CRO Nonclinical Studies Other (NewsroomExternalLinks)
  - Universal Flu Vaccine RFP (NewsroomExternalLinks)
  - AnthraxVaccine (NewsroomExternalLinks)
  - Animal Model Development RFP (NewsroomExternalLinks)
  - Continuous Manufacturing RFI (NewsroomExternalLinks)
  - AD BS Influenza Monoclonal Antibodies (NewsroomExternalLinks)
  - Emergent CIADM Ebola (NewsroomExternalLinks)
  - RFP for Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies (NewsroomExternalLinks)
  - DevAnthraxVaccine (NewsroomExternalLinks)
  - ExperimentalEbolaVaccine (NewsroomExternalLinks)
  - AllianceAntibioticDevelopment (NewsroomExternalLinks)
  - DevelopmentMonoclonalAntibodyEbola (NewsroomExternalLinks)
  - DisasterUseApprovedClotBusting (NewsroomExternalLinks)
  - DevelopmentHospitalizedInfluenzaPatients (NewsroomExternalLinks)
  - Novel drug to treat influenza (NewsroomExternalLinks)
  - NewProductSevereBurns (NewsroomExternalLinks)
  - ImproveInfluenzaVaccines (NewsroomExternalLinks)
  - PresolicitationBAAFlu (NewsroomExternalLinks)
  - Broad Agency Announcements (NewsroomArticles)
  - Coming Soon: Broad Agency Announcements (NewsroomExternalLinks)
  - New Skin Substitute (NewsroomExternalLinks)
  - Inhalational anthrax treatments (NewsroomExternalLinks)
  - Draft RFP Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
  - SSN Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
  - Manufacturing N95 Respirators (NewsroomExternalLinks)
- 2021 (contentTopForLists)
  - RegeneronPurchase (NewsroomArticles)
  - Lillyincrease (NewsroomArticles)
  - VisbyMedical (NewsroomArticles)
  - COVID19purchases (NewsroomArticles)
  - Luminex (NewsroomArticles)
  - LightDeck (NewsroomArticles)
  - JanssenEUA (NewsroomArticles)
  - Hologic assay4 (NewsroomArticles)
  - Lilly (NewsroomArticles)
  - MerckJ&J (NewsroomArticles)
  - MediciNova (NewsroomArticles)
  - ContraFect (NewsroomArticles)
  - NCATS (NewsroomArticles)
  - DiaSorinSpA (NewsroomArticles)
  - FirstString (NewsroomArticles)
  - MaskChallenge (NewsroomArticles)
  - Janssen (NewsroomArticles)
  - ortho (NewsroomArticles)
  - ebolataskforce (NewsroomArticles)
  - AgileMD (NewsroomArticles)
  - PeraHealth (NewsroomArticles)
  - BAAAntibacterial (NewsroomArticles)
  - BID2021Save (NewsroomArticles)
  - Ventures (NewsroomArticles)
  - TEMBEXA (NewsroomArticles)
  - LIAISON (NewsroomArticles)
  - Merck (NewsroomArticles)
  - Dascena (NewsroomArticles)
  - StrataGraft (NewsroomArticles)
  - Moderna (NewsroomArticles)
  - ARP (NewsroomArticles)
  - LightningTalks (NewsroomArticles)
  - BioAegis (NewsroomArticles)
  - Paratek (NewsroomArticles)
  - LightningTalksOpen (NewsroomArticles)
  - LightDeckDiag (NewsroomArticles)
  - Cepheid (NewsroomArticles)
  - USBiologic (NewsroomArticles)
  - Venatorx (NewsroomArticles)
  - Pediatric_Challenge (NewsroomArticles)
  - AZLAAB (NewsroomArticles)
  - Velico Medical (NewsroomArticles)
  - DRIVe_AOI10 (NewsroomArticles)
  - DRIVeAOI14 (NewsroomArticles)
  - Sentien (NewsroomArticles)
  - TATFAR (NewsroomArticles)
  - PTx (NewsroomArticles)
  - Orasure (NewsroomArticles)
  - ImmuneChip (NewsroomArticles)
  - Aidar2021 (NewsroomArticles)
  - Clarivate (NewsroomArticles)
  - Vedanta (NewsroomArticles)
  - SepsisTraining (NewsroomArticles)
  - COVIDDx (NewsroomArticles)
  - BD (NewsroomArticles)
  - RIVANNA (NewsroomArticles)
  - Pfizer_AV (NewsroomArticles)
  - ReDirect (NewsroomArticles)
  - Phase2Mask (NewsroomArticles)
  - MILE (NewsroomArticles)
- 2020 (contentTopForLists)
  - Novel Coronavirus (NewsroomExternalLinks)
  - nCoV Market Research (NewsroomArticles)
  - Coronavirus Emergency (NewsroomExternalLinks)
  - AUDENZTM H5N1 (NewsroomExternalLinks)
  - Regeneron Therapeutic (NewsroomExternalLinks)
  - nCoV EZ BAA (NewsroomExternalLinks)
  - Janssen Coronavirus (NewsroomExternalLinks)
  - Sanofi nCoV (NewsroomExternalLinks)
  - Janssen nCoV (NewsroomExternalLinks)
  - COVID19 Diagnostic (NewsroomExternalLinks)
  - Hologic Diagnostic (NewsroomArticles)
  - COVID-19 Diagnostic Test (NewsroomExternalLinks)
  - Cepheid Diagnostic (NewsroomArticles)
  - Mesa Biotech COVID-19 (NewsroomArticles)
  - Qiagen COVID-19 (NewsroomArticles)
  - DiaSorin COVID-19 (NewsroomArticles)
  - Janessen COVID-19 various (NewsroomArticles)
  - Moderna COVID-19 mRNA (NewsroomArticles)
  - Janssen Vaccine COVID-19 (NewsroomArticles)
  - Nanomix Diagnostic (NewsroomArticles)
  - Cue SARS-CoV-2 (NewsroomArticles)
  - Luminex NxTag Diagnostic (NewsroomArticles)
  - SAB-185 (NewsroomArticles)
  - Grilfols Plasma (NewsroomArticles)
  - GenMark Diagnostic (NewsroomArticles)
  - Luminex Aries Diagnostic (NewsroomArticles)
  - Emergent Plasma (NewsroomArticles)
  - Genetech (NewsroomArticles)
  - Plasma Immunotherapies (NewsroomArticles)
  - SNS Donations (1) (NewsroomArticles)
  - OraSure Diagnostic (NewsroomArticles)
  - DiaSorin (NewsroomArticles)
  - Vela Diagnostic (NewsroomArticles)
  - ARC Donors (NewsroomArticles)
  - PSC Sanofi Recombinant (NewsroomArticles)
  - Hememics Diagnostic (NewsroomArticles)
  - Tangen Diagnostic (NewsroomArticles)
  - Cytovale Diagnostic (NewsroomArticles)
  - Inbios Diagnostic (NewsroomArticles)
  - Americas Blood Centers (NewsroomArticles)
  - Cerus INTERCEPT (NewsroomArticles)
  - Hologic Assay (NewsroomArticles)
  - Mayo Clinic (NewsroomArticles)
  - Beckman Coulter (NewsroomArticles)
  - Phlow US Manufacturing (NewsroomArticles)
  - VitalConnect (NewsroomArticles)
  - Philips Lumify (NewsroomArticles)
  - COVID Vaccine (NewsroomArticles)
  - Merck IAVI (NewsroomArticles)
  - Genentech Therapeutic (NewsroomArticles)
  - Emergent Manufacturing (NewsroomArticles)
  - Quidel Diagnostic (NewsroomArticles)
  - Siemens Healthineers (NewsroomArticles)
  - Evidaton Health wearable (NewsroomArticles)
  - Moderna vaccine (NewsroomArticles)
  - AstraZeneca (NewsroomArticles)
  - ChembioZikaFDA (NewsroomArticles)
  - SepsisAlliance (NewsroomArticles)
  - Snapdragon (NewsroomArticles)
  - OraSurevitro (NewsroomArticles)
  - FDA EUA End (NewsroomExternalLinks)
  - Regeneron study (NewsroomArticles)
  - Immunexpress (NewsroomArticles)
  - OrthoClinicalDiagnostics (NewsroomArticles)
  - Corning (NewsroomArticles)
  - Empatica (NewsroomArticles)
  - MBio (NewsroomArticles)
  - CSU (NewsroomArticles)
  - Sonica (NewsroomArticles)
  - BID (NewsroomArticles)
  - Chembio DPP (NewsroomArticles)
  - SiO2 (NewsroomArticles)
  - NovavaxHHSDOD (NewsroomArticles)
  - RegeneronHHSDOD (NewsroomArticles)
  - LightningTalks2020 (NewsroomArticles)
  - RTI (NewsroomArticles)
  - BD (NewsroomArticles)
  - Smiths (NewsroomArticles)
  - Pfizer (NewsroomArticles)
  - TAMUS (NewsroomArticles)
  - LightningTalksApply (NewsroomArticles)
  - Moderna-Phase-3 (NewsroomArticles)
  - Sanofi_GSK (NewsroomArticles)
  - JanssenRapidARD (NewsroomArticles)
  - GrandRiver (NewsroomArticles)
  - Diasorin-Antibody-Test (NewsroomArticles)
  - ModernaManufacturing (NewsroomArticles)
  - BARDA-New-Partnerships (NewsroomArticles)
  - NOWDiagnostics (NewsroomArticles)
  - Marinus (NewsroomArticles)
  - 98point6 (NewsroomArticles)
  - OlogyBio (NewsroomArticles)
  - Ortho (NewsroomArticles)
  - UPenn (NewsroomArticles)
  - Luminex (NewsroomArticles)
  - LuminexNxTAG (NewsroomArticles)
  - Basilea (NewsroomArticles)
  - Invirsa (NewsroomArticles)
  - antibioticresistant (NewsroomArticles)
  - Mapp (NewsroomArticles)
  - BARDAMsg (NewsroomArticles)
  - Vaxxas (NewsroomArticles)
  - CurrentHealth (NewsroomArticles)
  - Cepheid (NewsroomArticles)
  - AstraZeneca2 (NewsroomArticles)
  - Cytiva (NewsroomArticles)
  - BeckmanCoulter (NewsroomArticles)
  - TRI (NewsroomArticles)
  - CSN (NewsroomArticles)
  - EZ-BAA (NewsroomArticles)
  - Lilly (NewsroomArticles)
  - InBios2 (NewsroomArticles)
  - Hologic (NewsroomArticles)
  - Humanigen (NewsroomArticles)
  - MesaBiotech (NewsroomArticles)
  - Ventures (NewsroomArticles)
  - BID2020Message (NewsroomArticles)
  - DiaSorinIgG (NewsroomArticles)
  - Siemens (NewsroomArticles)
  - SiemensCoV2Ag (NewsroomArticles)
  - Chrysalis (NewsroomArticles)
  - ENACT (NewsroomArticles)
  - Lilly2 (NewsroomArticles)
  - Chembio (NewsroomArticles)
  - GHTC (NewsroomArticles)
  - Moderna (NewsroomArticles)
  - QuantumLeap (NewsroomArticles)
  - Hologicassay (NewsroomArticles)
  - ModernaEUA (NewsroomArticles)
  - Ridgeback (NewsroomArticles)
  - Merck (1) (NewsroomArticles)
  - Pfizer (1) (NewsroomArticles)
  - Eoy2020 (NewsroomArticles)
  - Challenge (NewsroomArticles)
  - DiaSorinSimplexacombo (NewsroomArticles)
- 2016 (contentTopForLists)
  - Pre-Solicitation Biological Animal Model Development (NewsroomExternalLinks)
  - AntimicrobialResistancePartner (NewsroomExternalLinks)
  - Zika Blood Product (NewsroomExternalLinks)
  - New BSA Development (NewsroomExternalLinks)
  - Zika Diagnostics (NewsroomExternalLinks)
  - Decontamination Study (NewsroomExternalLinks)
  - Anthrax Diagnostic Test (NewsroomExternalLinks)
  - Nasal Anthrax Vaccine (NewsroomExternalLinks)
  - Pathogen Reduction Technologies (NewsroomExternalLinks)
  - CIADM Zika Vaccine (NewsroomExternalLinks)
  - Zika Vaccine Capacity Brazil (NewsroomExternalLinks)
  - Regional Ebola Treatment Center (NewsroomExternalLinks)
  - CARB-X (NewsroomExternalLinks)
  - Zika Diagnostic (NewsroomExternalLinks)
  - Single Dose Anthrax (NewsroomExternalLinks)
  - Zika Emergency Puerto Rico (NewsroomExternalLinks)
  - DiaSorin Zika (NewsroomExternalLinks)
  - OraSure Zika (NewsroomExternalLinks)
  - Chembio Zika (NewsroomExternalLinks)
  - Takeda Zika (NewsroomExternalLinks)
  - Moderna Zika (NewsroomExternalLinks)
  - AMR Prize (NewsroomExternalLinks)
  - New Antibiotics (NewsroomExternalLinks)
  - Zika Vaccine Sanofi (NewsroomExternalLinks)
  - Bioterrorism Antidote (NewsroomExternalLinks)
  - Genetic Sequencing Platform (NewsroomExternalLinks)
  - Next Gen Anthrax (NewsroomExternalLinks)
  - Tests ebola vaccine (NewsroomExternalLinks)
  - Test Radiation Absorbed (NewsroomExternalLinks)
  - Radiological Threats (NewsroomExternalLinks)
  - New BARDA Director (NewsroomExternalLinks)
- 2017 (contentTopForLists)
  - CARB-X Competition (NewsroomExternalLinks)
  - CARB-X Drug Discovery and Dev (NewsroomExternalLinks)
  - Zika Diagnostic (NewsroomExternalLinks)
  - High-Throughput Biodosimetry (NewsroomExternalLinks)
  - Point of Care Biodosimetry Tests (NewsroomExternalLinks)
  - RFP Biodosimetry POC (NewsroomExternalLinks)
  - RFP Biodosimetry High Throughput (NewsroomExternalLinks)
  - CARB-X Announces Funding for Global Scientists (NewsroomExternalLinks)
  - New Antibiotic (NewsroomExternalLinks)
  - Antibiotic Ridinilazole (NewsroomExternalLinks)
  - Janssen Influenza (NewsroomExternalLinks)
  - Cyanide Intranasal (NewsroomExternalLinks)
  - Anthrax POC Test (NewsroomExternalLinks)
  - Respiratory Drug Chemical Antidote (NewsroomExternalLinks)
  - Smallpox Vaccine Special Pop (NewsroomExternalLinks)
  - Ebola Vaccines (NewsroomExternalLinks)
  - Reusable Respirator (NewsroomExternalLinks)
  - Influenza and EID (NewsroomExternalLinks)
  - Radiation Exposure Tests (NewsroomExternalLinks)
  - Infection Antibiotic (NewsroomExternalLinks)
  - Radiation Blood Platelets (NewsroomExternalLinks)
  - CARB-X Amicidin-β (NewsroomExternalLinks)
  - 2018 BAA (NewsroomExternalLinks)
  - Anthrax Diagnostic (NewsroomExternalLinks)
- 2018 (contentTopForLists)
  - Leukine ARS (NewsroomExternalLinks)
  - ENACT and Sepsis (NewsroomArticles)
  - Decontamination (NewsroomExternalLinks)
  - DRIVe Funding (NewsroomExternalLinks)
  - Antrhrax SNS Purchase (NewsroomExternalLinks)
  - Nerve Agent (NewsroomExternalLinks)
  - Philadelphia Accelerator (NewsroomExternalLinks)
  - Houston Accelerator (NewsroomExternalLinks)
  - New York Accelerator (NewsroomExternalLinks)
  - New Orleans Accelerator (NewsroomExternalLinks)
  - Los Angeles Accelerator (NewsroomExternalLinks)
  - Greater Boston Accelerator (NewsroomExternalLinks)
  - Raleigh-Durham Accelerator (NewsroomExternalLinks)
  - Seattle-Bellevue Accelerator (NewsroomExternalLinks)
  - BID2018 (NewsroomArticles)
  - TPOXX (NewsroomExternalLinks)
  - Novel (NewsroomExternalLinks)
  - Lightning Talk Applications (NewsroomArticles)
  - flu test (NewsroomExternalLinks)
  - Sulfur Mustard (NewsroomExternalLinks)
  - Faster Tests (NewsroomExternalLinks)
  - Smallpox Antiviral (NewsroomExternalLinks)
  - Genentech (NewsroomExternalLinks)
  - Burn Dressing (NewsroomExternalLinks)
  - Security Threats (NewsroomExternalLinks)
- 2019 (contentTopForLists)
  - Expand Accelerators (NewsroomExternalLinks)
  - Marburg (NewsroomExternalLinks)
  - BurnDeepView (NewsroomExternalLinks)
  - VenatoRx (NewsroomExternalLinks)
  - SilverlonSulferMustard (NewsroomExternalLinks)
  - Lightning Talk Applications 2019 (NewsroomArticles)
  - Smallpox Vaccine Purchase SNS (NewsroomExternalLinks)
  - Expand Accelerator Network (NewsroomExternalLinks)
  - Investigational Ebola Treatment (NewsroomExternalLinks)
  - Smallpox and Monkeypox Licensed Vaccine (NewsroomExternalLinks)
  - Blood Platelets (NewsroomExternalLinks)
  - Filovirus Vaccines (NewsroomExternalLinks)
  - Lung Chip (NewsroomExternalLinks)
  - Lightning Talks Selectees (NewsroomArticles)
  - ebola RDT (NewsroomExternalLinks)
  - Sepsis Algorithm (NewsroomExternalLinks)
  - Cytovale Sepsis (NewsroomExternalLinks)
  - Bacterial from Viral (NewsroomExternalLinks)
  - Modernize Influenza (NewsroomExternalLinks)
  - Anthrax Lung Infections (NewsroomExternalLinks)
  - Ebola Vaccine (NewsroomExternalLinks)
- Archive (Content)
- Enalare (NewsroomArticles)
- Enalare (RedirectPage)
Federal Initiatives (FederalInitiatives)
- Public Meetings (contentFed)
  - BARDA Industry Day 2019 (conference)
    - Hotel Accommodations (Content)
    - Directions (Content)
    - About BARDA Industry Day (Content)
    - FAQ (Content)
    - Hybrid Events (Content)
    - Speakers (Content)
    - presentations (Content)
  - BARDA Industry Day 2017 (conference)
    - Presentations (Content)
    - About BARDA BID (Content)
    - Hotel Accommodations (Content)
    - Keynote Speaker (Content)
  - BARDA Industry Day 2016 (conference)
    - Why Attend (Content)
    - Meeting Opportunities (Content)
    - Hotel Accommodations (Content)
    - Breakout Session Opportunities (Content)
    - Presentations (Content)
  - BARDA Industry Day 2018 (conference)
    - Hotel Accommodations (Content)
    - Directions (Content)
    - About BARDA Industry Day (Content)
    - Presentations (Content)
    - Keynote Speaker (Content)
    - Lightning Talks (Content)
  - JPM-MCS Industry Day : Proposed Other Transaction Agreement (conference)
  - BARDA Industry Day 2015 (conference)
    - Why Attend (Content)
    - Meeting Opportunities (Content)
    - Hotel Accommodations (Content)
    - Presentations (Content)
  - MERS-CoV Preparedness Workshop (conference)
  - WorkshopBID2014 (conference)
    - Workshop2014WhyAttend (Content)
    - Workshop2014MeetingOpportunity (Content)
    - hotels (Content)
    - Presentations - BARDA Industry Day 2014 (Content)
  - WorkshopBID2013 (conference)
    - Workshop2013WhyAttend (Content)
    - Workshop2013MeetingOpportunity (Content)
    - hotels (Content)
    - Presentations - BARDA Industry Day 2013 (Content)
  - BAAPreProposalConference2013 (conference)
  - WorkshopBID2012 (conference)
    - Workshop2012MeetingOpportunity (Content)
    - Workshop2012WhoAttends (Content)
    - Workshop2012Register (Content)
    - Workshop2012WhyAttend (Content)
    - Presentations (Content)
    - Announcement1026 (Content)
    - Announcement1028 (Content)
  - PreProposalConference2012 (conference)
    - guidlines (Content)
  - BloodSymposium (conference)
  - WorkshopBID2011 (conference)
    - WorkshopBID2011Registration (Content)
    - WorkshopBID2011WhoAttends (Content)
    - WorkshopBID2011MeetingOpportunity (Content)
    - Presentations (Content)
  - WorkshopBoston (conference)
    - Presentations (Content)
    - WorkshopBostonWhoAttends (Content)
    - WorkshopBostonMeetingOpportunity (Content)
    - WorkshopBostonRegister (Content)
  - PHEMCE Stakeholders Workshop 2016 (conferenceLink)
  - 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day (conferenceLink)
  - HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day (conferenceLink)
  - CBRN Medical Countermeasures Workshop (conferenceLink)
  - HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day (conferenceLink)
  - 2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day (conferenceLink)
  - HHS PHEMC Enterprise Stakeholders Workshop (conferenceLink)
  - BioShield Stakeholders Workshop (conferenceLink)
  - BARDA Industry Day 2020 (conferenceLink)
  - BARDA Vaccines Against AMR Threats Workshop (conferenceLink)
  - BID2021 (conferenceLink)
  - 2022 Filovirus Workshop (conferenceLink)
  - BioMacIndustryDay (conferenceLink)
  - 2022 Filovirus Tx (conferenceLink)
  - BID 2022 (conferenceLink)
- Procurements and Grants (contentFed)
  - Federal Government Procurement Activities (contentFedItem)
  - Grants (contentFedItem)
  - Department and Agency Resources (contentFedItem)
  - Acquisition Regulations (contentFedItem)
  - Other Procurements and Grants Resources (contentFedItem)
- Strategies and Reports (contentFed)
  - Strategies and Reports (contentFedItem)
  - Public Health Emergency Medical Countermeasures Enterprise (contentFedItem)
  - NIH Strategic Planning (contentFedItem)
  - Pandemic Influenza (contentFedItem)
  - CBRN and Medical Countermeasure Reports (contentFedItem)
  - External Resources (contentFedItem)
- Guidance (contentFed)
  - Emergency Preparedness and Response (contentFedItem)
  - Drugs (contentFedItem)
  - Vaccines Blood and Biologics (contentFedItem)
  - Devices (contentFedItem)
  - Select Agent Rule (contentFedItem)
  - Animal Rule (contentFedItem)
  - Good Laboratory Practices (contentFedItem)
  - Technology Readiness Levels (contentFedItem)
  - Guidance Regarding Specific Types of Medical Countermeasures (contentFedItem)
  - Acquisition Regulations (contentFedItem)
- Resources (contentFed)
  - Microbiology (contentFedItem)
  - Immunology and Testing (contentFedItem)
  - Genomics (contentFedItem)
Request BARDA TechWatch Meeting (uSGCoronaWatch)
ContactUs (contactUs)
NewsroomRSS (Content)
HHSCentersForInnovation (GenericSingleColWithSideBarTop)
- Manufacturing Webinar (Content)
- PreposalcentersForInnovation2 (Content)
PhemceRSS (RedirectPage)
PhemceNewsroom (RedirectPage)
PHEMCE (pHEMCE)
- PHEMCE Strategy and Implementation (RedirectPage)
- Requirements Setting (GenericWithSideBar)
  - HHS PHEMCE Strategy (Content)
- NIH (RedirectPage)
- CDC (RedirectPage)
- DHS (RedirectPage)
- FDA (RedirectPage)
- DOD (RedirectPage)
- ASPR (RedirectPage)
ProjectMaps (ContentTop)
- Domestic (Content)
- International (Content)
- Who (Content)
- Summary (Content)
Conference Survey (Content)
2017 Conference Survey (Content)
Sitemap (Content)
XmlSitemap (xmlSiteMap)
BARDA (bardaNew)
- CBRN (cBRNNew)
  - Anthrax (RedirectPage)
    - Anthrax Antitoxins Program (RedirectPage)
    - Anthrax Vaccines Program (RedirectPage)
  - Botulinum Toxin (RedirectPage)
  - 2009CBRNWorkshop (Content)
    - 2009CBRNVideo1 (Content)
    - 2009CBRNVideo2 (Content)
  - Broad Spectrum Antimicrobials (RedirectPage)
  - Diagnostics and Biodosimetry (RedirectPage)
  - Project BioShield (Content)
    - Project BioShield Annual Report (RedirectPage)
    - Project BioShield Funding (RedirectPage)
  - Chemical Medical Countermeasures (1) (cBRNChemicalThreat)
  - CBRN Funding Activities (RedirectPage)
  - Ebola (Content)
    - Ebola Therapeutics Program (Subcontentwithtab)
    - Ebola Vaccines Program (Subcontentwithtab)
  - Thermal Burn (RedirectPage)
  - PRISM (cBRNPrism)
  - decontamination guidance for chemical incidents (RedirectPage)
  - Smallpox (Content)
    - Smallpox Antivirals Program (Subcontentwithtab)
    - Smallpox Vaccines Program (Subcontentwithtab)
  - MDRVaccines (aMR)
  - Vaccines (cBRNVaccine)
  - Antibacterials (cBRNAntibacterials)
  - Antivirals Antitoxins (cBRNAntiviralsAntitoxins)
  - Radiological and Nuclear Countermeasures (cBRNRadNuc)
  - Burn Blast (cBRNBurnAndBlast)
  - Chemical Medical Countermeasures (cBRNChemicalThreat)
  - Project BioShield Overview (RedirectPage)
- Core Services (coreServicesNew)
  - Medical Countermeasures for Smallpox (Content)
  - Radiological and Nuclear Threats (Content)
  - CBRN Diagnostics and Biodosimetry (Content)
  - Regulatory and Quality Affairs (RedirectPage)
  - Animal Studies Program (RedirectPage)
  - Clinical Studies Support (RedirectPage)
  - Strategic Investor (RedirectPage)
  - Modeling Hub (Content)
  - CIADM (RedirectPage)
    - CIADMGovernance (RedirectPage)
  - Fill Finish Manufacturing Network (RedirectPage)
  - Modeling Hub (RedirectPage)
- Advancing Innovation (innovationNew)
  - TechWatch (RedirectPage)
  - BARDA Sepsis Awareness Month (sepsis)
- Stockpile Building (GenericSingleColWithSideBar)
  - Project BioShield Annual Report (RedirectPage)
  - Project BioShield Funding (RedirectPage)
- Popular Resources (GenericSingleColWithSideBar)
- Influenza and Emerging Infectious Diseases (GenericSingleColWithSideBar)
  - Pandemic Influenza Preparedness Spending Reports (Content)
  - Influenza Vaccine Development Programs (Content)
  - Pandemic Influenza Vaccine Stockpile Program (Content)
  - Influenza Diagnostics Program (Content)
  - Influenza Therapeutics Program (Content)
  - Influenza Vaccine Manufacturing Infrastructure (Content)
  - International Influenza Vaccine Manufacturing Capacity Building Program (Content)
  - Coronavirus (GenericSingleColWithSideBar)
    - Pharmaceutical Manufacturing in America (manufacturing)
- PHEMCE Management (GenericWithSideBar)
  - HHS PHEMCE Strategy And Implementation (Content)
  - 2008 PHEMCE Stakeholders Workshop (Content)
  - 2010 PHEMCE Stateholders Workshop (Content)
    - 2010SWBeakoutSessions (Content)
    - 2010SWPresentations (Content)
    - 2010SWWhoAttends (Content)
    - 2010SWHotList (Content)
    - 2010SWContactUs (Content)
  - 2009 PHEMCE Stakeholders Workshop (Content)
    - 2009SWBreakoutSessions (Content)
    - 2009SWPresentations (Content)
    - 2009SWWhoAttends (Content)
    - 2009SWContactUs (Content)
  - 2007 BARDA Day (Content)
  - 2007 PHEMCE Stakeholders Workshop (Content)
  - 2006 BioShield Stakeholders Workshop (Content)
    - 2006 BioShield Agenda (Content)
- Requirements Setting (GenericWithSideBar)
  - HHS PHEMCE Strategy (Content)
- Emerging Infectious Diseases (RedirectPage)
  - Zika (RedirectPage)
  - Ebola (RedirectPage)
- BARDA COVID-19 Response (covid19New)
- WhoWeAre (whoWeAreNew)
- BARDA Industry Day 2020 (bid)
  - LT Selectees (bIDStdSubpageNew)
  - Bid Presentations (bIDStdSubpageNew1)
- BARDA BAA (bAANew)
- FAQ 2020 (fAQNew)
- Series (seriesNew)
  - QIAGEN LLC (seriesItem2020)
  - Cytovale Inc. (seriesItem2020)
  - Nanomix Inc. (seriesItem2020)
  - Cue Inc. (seriesItem2020)
  - GenMark Diagnostics, Inc. (seriesItem2020)
  - Emergent BioSolutions (seriesItem2020)
  - Ortho Clinical Diagnostics (seriesItem2020)
  - Empatica Inc. (seriesItem2020)
  - Mesa Biotech Inc. (seriesItem2020)
  - Grifols (seriesItem2020)
  - Cerus (seriesItem2020)
  - Immunexpress Inc. (seriesItem2020)
  - Janssen Research & Development, LLC (seriesItem2020)
  - Luminex Corporation (seriesItem2020)
  - Retractable Technologies, Inc. (seriesItem2020)
  - OraSure Technologies, Inc. (seriesItem2020)
  - SiO2 Materials Science (seriesItem2020)
  - MBio Diagnostics (seriesItem2020)
  - Tangen Biosciences, Inc. (seriesItem2020)
  - Colorado State University (seriesItem2020)
  - InBios (seriesItem2020)
  - Smiths Medical (seriesItem2020)
  - Corning Incorporated (seriesItem2020)
  - Grand River Aseptic Manufacturing, Inc. (seriesItem2020)
  - SAb Biotherapeutics (seriesItem2020)
  - Chembio (seriesItem2020)
  - Making Countermeasures (seriesVideoItem2020)
  - ImpactBurnCare (seriesItem2020)
  - Numerous (seriesItem2020)
- Be A Responder (joinTheFightNew)
- FDAapprovals (fDANew)
- Research (bardaResearchNew)
  - Impact of Bacterial Infections (bardaResearchItemNew)
  - PartneringonvaccinesMDR (bardaResearchItemNew)
  - BARDA Staff-Authored Research (bardaResearchItemNew)
  - ketamine to standard-of-care (bardaResearchItemNew)
  - pharmacokinetics of ketamine (bardaResearchItemNew)
  - Scopolamine for VX Nerve Agent (bardaResearchItemNew)
  - SARS0CoV-2 assays (bardaResearchItemNew)
  - H3N2 Vaccine (bardaResearchItemNew)
  - Filovirus Isolates for Vaccine Dev (bardaResearchItemNew)
  - Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) (bardaResearchItemNew)
  - Development of a clinical assay to measure chlorinated tyrosine (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Evaluation of BioThrax® and AV7909 Anthrax Vaccines in Adults 66 Years of Age or Older (bardaResearchItemNew)
  - Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus (bardaResearchItemNew)
  - Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward (bardaResearchItemNew)
- Working at BARDA (workingAtBARDA)
- BARDA Industry Day 2021 (bID2021)
  - LT Selectees (bID2021LTSelectees)
- Strategic Plan (strategicPlan)
- DDDI (cBRNDDDI1)
Video Library (videoLibrary)
- CBRNDirectorBID2020 (videoLibraryVideo)
- BARDACOVIDResponse (videoLibraryVideo)
- COVID19_MCM Investments (videoLibraryVideo)
- MakingCountermeasuresSeries (videoLibraryVideo)
- DirectorEUA (videoLibraryVideo)
- DRIVEProgram (videoLibraryVideo)
- AMR Workshop (videoLibraryVideo)
- CARBXPartnership (videoLibraryVideo)
- BioTalkCatalyst (videoLibraryVideo)
- COVIDVaccineHesitancy (videoLibraryVideo)
- ASKBARDA_CTPaused (videoLibraryVideo)
- ASKBARDA_CTSafety (videoLibraryVideo)
- ASKBARDA_CTPlanned (videoLibraryVideo)
- ASKBARDA_CTPlacebo (videoLibraryVideo)
- ASKBARDA_CTDSMB (videoLibraryVideo)
- ASKBARDA_CTOutcome (videoLibraryVideo)
- PublicPrivatePartnerships (videoLibraryVideo)
- PBS_BuildMCM (videoLibraryVideo)
- CARBXDRIVE (videoLibraryVideo)
- DRIVeInnovation (videoLibraryVideo)
- BeyondLab (videoLibraryVideo)
- BID2020 (videoLibraryVideo)
- Ventures Disbrow June2021 (videoLibraryVideo)
- Ventures Patel June2021 (1) (videoLibraryVideo)
- Ventures Yang June2021 (videoLibraryVideo)
- BID2021 (videoLibraryVideo)
- BID_Firesidechat (videoLibraryVideo)
- DRIVeWearablesSummit (videoLibraryVideo)
- BS:BARDA Director Introduction (videoLibraryVideo)
- BS:Preparedness (videoLibraryVideo)
- BS:Response (videoLibraryVideo)
- BS:Partnerships (videoLibraryVideo)
- BS:Workforce (videoLibraryVideo)
Blogs (blogs)
- BARDAVentures (blog)
- InnovationChallenge (blog)
- Antibiotic Partnerships (blog)
- Ebola Efforts Continue (blog)
- Strong partnerships next generation antibiotics (blog)
- Flu Drug Earns FDA Approval (blog)
- Reflections on antibiotic resistance (blog)
- Crash Course (blog)
- Zika receives FDA Clearance (blog)
- Evolving Federal National Health Security (blog)
- 50 Million Diagnostic Tests Shipped (blog)
- Clinical Synergies (blog)
- Sepsis Solutions Help Covid Patients (blog)
- Critical Time For Public Service (blog)
- Raising Awareness (blog)
- BARDA Leverages Strong Partnerships (blog)
- Sepsis Skyrocketing (blog)
- Vaccine Uses Next Gen Technology (blog)
- Need for Speed (blog)
- Threat In My Backyard (blog)
- Power of Partnerships (blog)
- Close Encounter (blog)
- Crossing The Finish Line (blog)
- Novel Partnerships (blog)
- Building Better Pipeline of Products (blog)
- Leveraging Project BioShield (blog)
- Strengthening Antibiotics Pipeline (blog)
- Ebola Therapeutic (blog)
- Business Models to Enhance Antibiotic Development (blog)
- BSA Program (blog)
- Responding to the Threat (blog)
- Antibiotic Resistance and Why a Problem (blog)
- Changing Pandemic Influenza Vaccine Manufacturing (blog)
- Build and Sustain Robust MCM Pipeline (blog)
- Award Winning Pan Flu Preparedness (blog)
- Plan to Keep the Nation Safe (blog)
- Can Rapid, Near-Patient Flu Tests Improve Preparedness and Response (blog)
- BioShield (blog)
- Pandemic Influenza (blog)
- FDA Anti Seizure (blog)
- BARDA Partners (blog)
- New Smallpox (blog)
- 1918 to 2018 (blog)
- Decontamination Decoded (blog)
- BARDA Supports a Rapid Deployable (blog)
- BARDA Adds New Antibiotic (blog)
- New Frontiers and Extreme Environments (blog)
- Powering The Next Gen (blog)
- Next Generation Burn Care (blog)
- Better Preparing (blog)
- Anticipating Threats (blog)
- PHEMCE-Supported Drug Achieves FDA Approval (blog)
- Would Old Vaccine Work (blog)
- BARDA Seeks to Launch a Novel Partnership (blog)
- Better Protecting (blog)
- Bird Flu (blog)
- Fighting Antibiotic Resistance (blog)
- BARDA-Supported Zika Vaccine Candidate (blog)
- AMR (blog)
- PartneringtoProtect (blog)
- Curb AMR (blog)
- RespondMonkeyPox (blog)
Stories (stories)
- Ebola Story (story)
- MaskChallenge (story)
- RQA_SME (story)
- Correlates of Protection (story)
- Wearables (story)
- Combating AMR (story)
- MaskPrototype (story)
- BARDA15 (story)
- PediatricChallengeData (story)
- MaskFinalists (story)
- Monkeypox (story)

Sitemap

Navigation

Resources

Popular

Social Media

I WANT TO FIND

Sitemap